SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as the crypto market experiences volatility, leading to discussions about potential manipulation tactics and the influence of large holders like BlockRock. Community members are debating whether this is a buying opportunity or a sign of further declines, with some pointing to historical patterns and Elliott Wave analysis. The conversation also includes speculation about future price targets, regulatory impacts, and Bitcoin's role as an asset.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending as investors debate the company's cash balance and future prospects, particularly the potential impact of a large AI data center contract. Community discussions revolve around the CEO's promises, the possibility of a share buyback, and whether the stock is currently undervalued given its pipeline and cash reserves. Some are skeptical of the company's reporting and market sentiment.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Starknet is trending amid a breakout from a rounding-bottom pattern, sparking bullish sentiment and speculation of a Wave 3 move toward higher targets. Community excitement is fueled by increasing staking volume and Bitcoin DeFi (BTCFi) incentives, with analysts noting strong buyer support and clean price action. The focus remains on Starknet's technology and potential for scalability within the crypto space.

Aventus Network

Aventus Network ($AVT) is trending as community members discuss its potential for a breakout, citing its integration with Polkadot and its real-world partnerships. Traders are closely monitoring volume, particularly with news of a new listing, which could drive the price higher. Bullish sentiment is strong, with some suggesting the token is undervalued and poised for significant gains.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending amid discussions about new aircraft orders, potential deals in the defense sector, and advancements in their SMR (small modular reactor) technology. Community members are closely monitoring the Dubai Airshow for potential widebody aircraft orders and awaiting further details from the company's trading update. Speculation around new SMR contracts and the possibility of India becoming a key market are also fueling interest.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals ($OLMA) is trending due to a presentation of trial-in-progress data for its Phase 3 OPERA-02 trial, generating community discussion about its potential in breast cancer treatment and comparisons to competitors like Roche. Some are optimistic about the data and analysts' price targets, while others focus on the company's financial risks and recent insider selling, with speculation about a potential buyout adding to the buzz.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu (BIDU) is trending as investors digest recent earnings beats and debate the stock's valuation as an AI play. Bullish sentiment highlights its cheap valuation and potential for growth in the AI sector, while bears point to concerns of China's economic climate. The community is actively discussing upcoming catalysts and whether BIDU can maintain its momentum.

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Zymeworks Inc

Zymeworks is trending due to renewed interest in its clinical pipeline and collaboration updates, particularly surrounding Zymeworks' HER2-targeted agent, Ziihera. Community discussions highlight the potential for milestone payments and royalties, as well as a possible acquisition target for Jazz Pharmaceuticals. Some traders are also noting a high short interest, anticipating a potential short squeeze.

PolySwarm

PolySwarm ($NCT) is trending as traders discuss its potential for a rebound, citing its position in the cybersecurity sector and fully circulated token supply. The community is actively debating entry points and anticipating a breakout, with some expressing frustration over recent price action while others emphasize long-term holding. Broader market factors, including potential FED rate cuts and their impact on altcoins, are also being considered.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as analysts boost price targets, citing strong AI server demand and long-term growth potential, with investors anticipating details from an upcoming analyst day. The community is discussing whether the stock is undervalued, while noting its historical performance and potential for significant upside. Some traders are also weighing concerns about profit margins and potential pullbacks, while tracking key support levels.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

121,667 Shares in Adaptive Biotechnologies Corporation $ADPT Purchased by Hedeker Wealth LLC

Hedeker Wealth LLC purchased a new stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) in the second quarter, according to its most recent 13F filing with the Securities...

Jupiter Asset Management Ltd. Makes New Investment in Adaptive Biotechnologies Corporation $ADPT

Jupiter Asset Management Ltd. acquired a new position in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) in the 2nd quarter, according to its most recent filing with the...

Adaptive Biotechnologies Corporation $ADPT Shares Acquired by Calamos Advisors LLC

Calamos Advisors LLC increased its stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 52.3% during the 2nd quarter, according to the company in its most recent 13F filing...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells 1,237 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 1,237 shares of the company's stock in a transaction on Tuesday, November 11th. The stock was sold at an...

Chad Robins Sells 1,867 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 1,867 shares of the company's stock in a transaction that occurred on Wednesday, November 12th. The stock was...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Harlan Robins Sells 10,000 Shares

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 10,000 shares of the stock in a transaction dated Monday, November 10th. The stock was sold at an...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells 86,161 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 86,161 shares of the firm's stock in a transaction on Monday, November 10th. The stock was sold at an average...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells 1,867 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 1,867 shares of the business's stock in a transaction on Wednesday, November 12th. The shares were sold at an...

Adaptive Biotechnologies (NASDAQ:ADPT) Given New $16.00 Price Target at Morgan Stanley

Morgan Stanley upped their target price on Adaptive Biotechnologies from $11.00 to $16.00 and gave the stock an "equal weight" rating in a research report on Tuesday...

Adaptive Biotechnologies (NASDAQ:ADPT) Upgraded at Wall Street Zen

Wall Street Zen upgraded Adaptive Biotechnologies from a "hold" rating to a "buy" rating in a report on Saturday...

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Adaptive Biotechnologies Corp

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.18	--	--	N/A
Q3 '25	-$0.15	$0.06	140.93%	BEAT
Q2 '25	-$0.24	-$0.17	28.80%	BEAT
Q1 '25	-$0.29	-$0.20	31.50%	BEAT
Q4 '24	-$0.26	-$0.23	10.24%	BEAT

ADPT
Adaptive Biotechnologies Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest ADPT News

ADPTAdaptive Biotechnologies Corp